Adjuvant Therapy With Nivolumab Versus Placebo in Patients With Resected Stage IIB/C Melanoma (Checkmate 76K)

被引：0

作者：

Gastman, Brian ^{[1
]}

Long, Georgina V. ^{[2
]}

Kirkwood, John M. ^{[3
]}

Hoeller, Christoph ^{[4
,5
]}

Weber, Jeffrey ^{[6
]}

Grob, Jean-Jacques ^{[7
]}

Mohr, Peter ^{[8
]}

Grabbe, Stephan ^{[9
]}

Dutriaux, Caroline ^{[10
]}

Chiarion-Sileni, Vanna ^{[11
]}

Mackiewicz, Jacek ^{[12
]}

Rutkowski, Piotr ^{[13
]}

Arenberger, Petr ^{[14
,15
]}

Quereux, Gaelle ^{[16
]}

Meniawy, Tarek ^{[17
]}

Ascierto, Paolo A. ^{[18
]}

van Akkooi, Alexander ^{[19
,20
]}

Durani, Piyush ^{[21
]}

Campigotto, Federico ^{[21
]}

Del Vecchio, Michele ^{[22
]}

机构：

[1] Cleveland Clin Fdn, Melanoma & High Risk Skin Canc Program, Cleveland, OH USA

[2] Univ Sydney, Melanoma Inst Australia, Royal North Shore & Mater Hosp, Sydney, NSW, Australia

[3] UPMC Hillman Canc Ctr, Melanoma & Skin Canc P, Med Dermatol, Pittsburgh, PA USA

[4] Med Univ Wien, Dermatol, Vienna, Austria

[5] Med Univ Wien, Skin Canc Ctr, Vienna, Austria

[6] NYU Langone Med Ctr, Perlmutter Canc Ctr, New York, NY USA

[7] Hop La Timone, Dermatol, Marseille, France

[8] Elbe Klinikum Buxtehude, Buxtehude, Germany

[9] Univ Mainz Med Ctr, Dermatol, Mainz, Germany

[10] Hop St Andre, Bordeaux, France

[11] IRCCS, Ist Oncol Veneto, Melanoma & Esophageal Oncol Unit, San Giovanni Rotondo, Italy

[12] Poznan Univ Med Sci, Poznan, Poland

[13] Maria Sklodowska Curie Natl Res Inst Oncol, Surg Oncol, Warsaw, Poland

[14] Charles Univ Prague, Fac Med 3, Dept Dermatovenereol, Prague, Czech Republic

[15] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic

[16] Nantes Univ Hosp, Nantes, France

[17] 15Sir Charles Gairdner Hosp, City Beach, WA USA

[18] Ist Nazl Tumori IRCCS Fdn G Pascale, Unit Melanoma Canc Immunotherapy & Innovat Therap, Canc Immunotherapy & Dev Therapeut Unit, Naples, Italy

[19] Univ Sydney, Melanoma Inst Australia, Fac Med & Hlth, Sydney, NSW, Australia

[20] Royal Prince Alfred Hosp, Sydney, NSW, Australia

[21] Bristol Myers Squibb, Global Oncol Clin Dev, New York, NY USA

[22] Fdn IRCCS Ist Nazl Tumori, Unit Melanoma Med Oncol, Milan, Italy

来源：

ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S35 / S36

页数：2

共 50 条

[41] REAL-WORLD OUTCOMES OF PATIENTS WITH RESECTED STAGE IIIA MELANOMA TREATED WITH ADJUVANT NIVOLUMAB IN A US COMMUNITY SETTING
Samlowski, Wolfram
Chan, Phillip
Pavlick, Anna
Moser, Justin
Robert, Nicholas
Poreta, Tayla
Moshyk, Andriy
Sakkal, Leon
Palaia, Jennell
Niehoff, Nicole
Rajkumar, Jonathan
Amin, Asim
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A451 - A451
[42] Phase III study of adjuvant encorafenib plus binimetinib versus placebo in fully resected stage IIB/C BRAFV600-mutated melanoma: COLUMBUS-AD study design.
Van Akkooi, Alexander Christopher Jonathan
Hauschild, Axel
Long, Georgina V.
Mandala, Mario
Kicinski, Michal
Govaerts, Anne-Sophie
Klauck, Isabelle
Ouali, Monia
Lorigan, Paul
Eggermont, Alexander M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[43] Propensity weighted indirect treatment comparison of nivolumab (NIVO) versus placebo (PBO) as adjuvant therapy for resected melanoma: A number needed to treat and overall survival analysis.
Weber, Jeffrey S.
Poretta, Tayla
Stwalley, Brian
Sakkal, Leon
Du, Ella X.
Wang, Travis
Chen, Yan
Wang, Yan
Betts, Keith A.
Shoushtari, Alexander Noor
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[44] Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage III/IV melanoma: Updated results from a phase III trial (CheckMate 238).
Weber, Jeffrey S.
Mandala, Mario
Del Vecchio, Michele
Gogas, Helen
Arance, Ana M.
Cowey, Charles Lance
Dalle, Stephane
Schenker, Michael
Chiarion-Sileni, Vanna
Rodas, Ivan Marquez
Grob, Jean-Jacques
Butler, Marcus
Middleton, Mark R.
Maio, Michele
Atkinson, Victoria
Dummer, Reinhard
de Pril, Veerle
Qureshi, Anila H.
Larkin, James M. G.
Ascierto, Paolo Antonio
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[45] Phase III KEYNOTE-716 study: Adjuvant therapy with pembrolizumab versus placebo in resected high-risk stage II melanoma.
Luke, Jason J.
Ascierto, Paolo Antonio
Carlino, Matteo S.
Eggermont, Alexander M. M.
Grob, Jean-Jacques
Hauschild, Axel
Kirkwood, John M.
Long, Georgina V.
Mohr, Peter
Robert, Caroline
Gershenwald, Jeffrey E.
Poklepovic, Andrew Stewart
Ross, Merrick I.
Scolyer, Richard A.
Yoon, Charles
Anderson, James R.
Ahsan, Sama
Ibrahim, Nageatte
Sondak, Vernon K.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
[46] Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data
Morganna Freeman
Keith A. Betts
Shan Jiang
Ella X. Du
Komal Gupte-Singh
Yichen Lu
Sumati Rao
Alexander N. Shoushtari
Advances in Therapy, 2019, 36 : 2783 - 2796
[47] Phase III study of adjuvant therapy with encorafenib plus binimetinib compared to placebo in completely resected BRAFV600-mutant stage IIB/C melanoma: study design of the COLUMBUS-AD
Hauschild, A.
Van Akkooi, A. C. J.
Long, G. V.
Mandala, M.
Kicinski, M.
Govaerts, A. S.
Klauck, I.
Ouali, M.
Lorigan, P. C.
Eggermont, A. M. M.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 96 - 96
[48] Adjuvant Therapeutic Decisions in Patients with Stage IIB/C and Stage III malignant Melanoma in everyday Clinical Practice
Mechow, N.
Peitsch, W. K.
Diehl, K.
Ohletz, J.
Herz, J.
Eisert, L.
Harth, W.
Weilandt, J.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 : 24 - 24
[49] Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data
Freeman, Morganna
Betts, Keith A.
Jiang, Shan
Du, Ella X.
Gupte-Singh, Komal
Lu, Yichen
Rao, Sumati
Shoushtari, Alexander N.
ADVANCES IN THERAPY, 2019, 36 (10) : 2783 - 2796
[50] HEALTHCARE COSTS COMPARISON OF NIVOLUMAB VERSUS PLACEBO AS ADJUVANT TREATMENT OF PATIENTS WITH MELANOMA: A PROPENSITY SCORE MATCHED ANALYSIS
Pandey, S.
Sharma, A.
Siddiqui, M. K.
Amadi, A.
VALUE IN HEALTH, 2020, 23 : S432 - S433

← 1 2 3 4 5 →